Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 60 Stomach Neoplasms 27 Rectal Neoplasms 20 Colonic Neoplasms 19 Small Cell Lung Carcinoma 12 Pancreatic Neoplasms 11 Neoplasm Metastasis 10 Locally Advanced Rectal Cancer 5 Colorectal Cancer Metastatic 5 Esophageal Squamous Cell Carcinoma 4 Esophageal Neoplasms 4 Biliary Tract Neoplasms 4 Recurrence 3 Liver Neoplasms 3 Glioblastoma 3 Cholangiocarcinoma 3 Carcinoma, Non-Small-Cell Lung 3 Breast Neoplasms 3 Solid Tumors 2 Sarcoma 2 Lung Neoplasms 2 Glioma 2 Gastrointestinal Neoplasms 2 Gallbladder Neoplasms 2 Advanced Gastric Cancer Adenocarcinoma of Esophagogastric Junction 2 Advanced Colorectal Cancer 2 mCRC 1 Unspecified Adult Solid Tumor, Protocol Specific 1 Thrombocytopenia 1 Second Line Treatment of Gastric Cancer 1

Interventions

raltitrexed 1 Oxaliplatin 1 Irinotecan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Colon Cancer Liver Metastasis × Irinotecan × Clear all

NCT03175016 2017-06-27

DEBIRI-CRLM

Tianjin Medical University Cancer Institute and Hospital

Phase 2/3 Unknown

Gastrointestinal

Colon Cancer Liver Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡